Swidsinski Alexander, Dörffel Yvonne, Loening-Baucke Vera, Gille Christoph, Reißhauer Anne, Göktas Onder, Krüger Monika, Neuhaus Jürgen, Schrödl Wieland
Alexander Swidsinski, Vera Loening-Baucke, Christoph Gille, Anne Reißhauer, Onder Göktas, Laboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Department of Medicine, Section of Gastroenterology, Hepatology and Endocrinology, Charité Universitätsmedizin Berlin, 10098 Berlin, Germany.
World J Gastroenterol. 2017 Feb 7;23(5):885-890. doi: 10.3748/wjg.v23.i5.885.
To test the effects of humic acids on innate microbial communities of the colon.
We followed the effects of oral supplementation with humic acids (Activomin) on concentrations and composition of colonic microbiome in 14 healthy volunteers for 45 d. 3 × 800 mg Activomin were taken orally for 10 d followed by 3 × 400 mg for 35 d. Colonic microbiota were investigated using multicolor fluorescence hybridization (FISH) of Carnoy fixated and paraffin embedded stool cylinders. Two stool samples were collected a week prior to therapy and one stool sample on days 10, 31 and 45. Forty-one FISH probes representing different bacterial groups were used.
The sum concentration of colonic microbiota increased from 20% at day 10 to 30% by day 31 and remained stable until day 45 (32%) of humic acid supplementation ( < 0.001). The increase in the concentrations in each person was due to growth of preexisting groups. The individual microbial profile of the patients remained unchanged. Similarly, the bacterial diversity remained stable. Concentrations of 24 of the 35 substantial groups increased from 20% to 96%. Two bacterial groups detected with Bac303 () and Myc657 (mycolic acid-containing ) FISH probes decreased ( > 0.05). The others remained unaffected. Bacterial groups with initially marginal concentrations (< 0.1 × 10/mL) demonstrated no response to humic acids. The concentrations of pioneer groups of , and increased but the observed differences were statistically not significant.
Humic acids have a profound effect on healthy colonic microbiome and may be potentially interesting substances for the development of drugs that control the innate colonic microbiome.
测试腐殖酸对结肠固有微生物群落的影响。
我们追踪了14名健康志愿者口服腐殖酸(活性腐殖酸)45天对结肠微生物群浓度和组成的影响。口服3×800毫克活性腐殖酸,持续10天,随后口服3×400毫克,持续35天。使用卡诺固定并石蜡包埋的粪便柱状样本进行多色荧光杂交(FISH)来研究结肠微生物群。在治疗前一周收集两份粪便样本,并在第10、31和45天收集一份粪便样本。使用了41种代表不同细菌群的FISH探针。
结肠微生物群的总浓度从第10天的20%增加到第31天的30%,并在腐殖酸补充的第45天(32%)保持稳定(P<0.001)。每个人浓度的增加是由于原有菌群的生长。患者的个体微生物谱保持不变。同样,细菌多样性保持稳定。35个主要菌群中的24个菌群浓度从20%增加到96%。用Bac303()和Myc65(含分枝菌酸的)FISH探针检测到的两个细菌群减少(P>0.05)。其他菌群未受影响。初始浓度较低(<0.1×10/mL)的细菌群对腐殖酸无反应。、和的先锋菌群浓度增加,但观察到的差异无统计学意义。
腐殖酸对健康的结肠微生物群有深远影响,可能是开发控制结肠固有微生物群药物的潜在有趣物质。